A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain | NEJM Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not been established. We randomly assigned participants 45 to 85 years of ag...

Excited to share the results of the TeMPO (Treatment of Meniscal Problems in Osteoarthritis) trial, published today in NEJM: www.nejm.org/doi/full/10....

A labor of love from the #BWH #oracore team, with partners in Buffalo, Pittsburgh, and Cleveland. 879 randomized with the COVID in the middle!

very proud of our 2nd year #OrACORe research assistants at #ACR25! Sasha Aronson spoke yesterday about cost-effectiveness of PT for people with OA and meniscal tear, and Ethan Eickmann presented a poster today on expanding indications for GLP1s in OA. 👏👏

Ongoing Projects – OrACORe

#OrACOrE Director Dr. Elena Losina will speak this afternoon at the session, "Designing Stronger Clinical Trials: Choosing the Best Comparator for Impactful Results." Read about some of Dr. Losina's ongoing trials in orthopedics and rheumatology here: oracore.bwh.harvard.edu/ongoing-proj...
#ACR25

New from #OrACORe in @oacjournal.bsky.social: Longitudinal associations between bilateral vs unilateral knee osteoarthritis and physical performance. Contrary to our hypothesis we did not find associations between bilateral disease & worsening physical function
www.sciencedirect.com/science/arti...

GLP-1 Drugs Shown Cost-Effective for Knee Osteoarthritis and Obesity | Mass General Brigham Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients. For eligible and willing patients, bariatric surgery provides the best optio...

New from #OrACORe and #PIVOT: The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity

www.massgeneralbrigham.org/en/about/new...

#oracore Clinical Director Dr. Jeff Katz presents “Intervention Effects Unpacked” at #OARSI2025